Clinical trial

Post-Treatment Effects of Naltrexone

NCT00006449 · Indiana University, Other · Completed

Key facts

NCT number NCT00006449
Title Post-Treatment Effects of Naltrexone
Official title Post-Treatment Effects of Naltrexone
Lead sponsor Indiana University, Other
Collaborators National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions Alcoholism
Intervention type Behavioral, Drug
Interventions naltrexone (Revia), broad spectrum treatment, motivational enhancement therapy
Enrollment 160
Start date Sep 1, 2000
Completion Jul 1, 2006
First posted Nov 7, 2000
Last update posted May 12, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies